Brief: SynAct Receives Notice Of Allowance For Grant Of U.S. Patent
23/04/2025 07:05
April 23 (Reuters) - SynAct Pharma AB SYNACT.ST: SYNACT RECEIVES NOTICE OF ALLOWANCE FOR GRANT OF US PATENT COVERING RESOMELAGON (AP1189) COMBINATION THERAPY US PATENT, WHEN ISSUED, CAN BE ENFORCED AT LEAST UNTIL 2040 Source text: ID:nMFN5T4Lzd Further company coverage: SYNACT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026